157 related articles for article (PubMed ID: 30993899)
1. Mortality of lung cancer as a second primary malignancy: A population-based cohort study.
Deng L; Harðardottír H; Song H; Xiao Z; Jiang C; Wang Q; Valdimarsdóttir U; Cheng H; Loo BW; Lu D
Cancer Med; 2019 Jun; 8(6):3269-3277. PubMed ID: 30993899
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy.
Wang C; Hu K; Deng L; He W; Fang F; Tamimi RM; Lu D
BMC Cancer; 2021 May; 21(1):491. PubMed ID: 33941118
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of the 8th edition AJCC TNM staging system for non-small-cell lung cancer is not applicable to lung cancer as a second primary malignancy.
Shi S; Xie H; Yin W; Zhang Y; Peng X; Yu F; Shemanski KA; Kim AW; Wang X
J Surg Oncol; 2020 Jun; 121(8):1233-1240. PubMed ID: 32170977
[TBL] [Abstract][Full Text] [Related]
4. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.
Milano MT; Li H; Constine LS; Travis LB
Cancer; 2011 Dec; 117(24):5538-47. PubMed ID: 21692074
[TBL] [Abstract][Full Text] [Related]
5. Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis.
Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
Lung Cancer; 2016 Aug; 98():106-113. PubMed ID: 27393515
[TBL] [Abstract][Full Text] [Related]
6. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008.
Donin N; Filson C; Drakaki A; Tan HJ; Castillo A; Kwan L; Litwin M; Chamie K
Cancer; 2016 Oct; 122(19):3075-86. PubMed ID: 27377470
[TBL] [Abstract][Full Text] [Related]
7. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
8. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
9. Survival analysis of patients with primary breast duct carcinoma and lung adenocarcinoma: a population-based study from SEER.
Lv F; Cheng M; Jiang L; Zhao X
Sci Rep; 2021 Jul; 11(1):14790. PubMed ID: 34285322
[TBL] [Abstract][Full Text] [Related]
10. Atypical carcinoid tumor of the lung: a surveillance, epidemiology, and end results database analysis.
Steuer CE; Behera M; Kim S; Chen Z; Saba NF; Pillai RN; Owonikoko TK; Khuri FR; Ramalingam SS
J Thorac Oncol; 2015 Mar; 10(3):479-85. PubMed ID: 25371080
[TBL] [Abstract][Full Text] [Related]
11. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
12. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
Abhyankar N; Hoskins KF; Abern MR; Calip GS
BMC Cancer; 2017 Sep; 17(1):659. PubMed ID: 28946846
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of secondary solid tumor malignancies among patients with myeloma: A population-based study.
Barth P; Castillo JJ; Olszewski AJ
Cancer; 2019 Feb; 125(4):550-558. PubMed ID: 30452087
[TBL] [Abstract][Full Text] [Related]
14. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
Saad AM; Al-Husseini MJ; Elgebaly A; Aboshady OA; Salahia S; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):417-423. PubMed ID: 29316808
[TBL] [Abstract][Full Text] [Related]
15. Analysis of second primary lung cancers in the SEER database.
Bhaskarla A; Tang PC; Mashtare T; Nwogu CE; Demmy TL; Adjei AA; Reid ME; Yendamuri S
J Surg Res; 2010 Jul; 162(1):1-6. PubMed ID: 20400118
[TBL] [Abstract][Full Text] [Related]
16. Second primary lung cancer in United States Cancer Survivors, 1992-2008.
Donin NM; Kwan L; Lenis AT; Drakaki A; Chamie K
Cancer Causes Control; 2019 May; 30(5):465-475. PubMed ID: 30900065
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
18. Subsequent thoracic cancers among patients diagnosed with lung cancer: a SEER database analysis.
Abdel-Rahman O; Cheung WY
Curr Med Res Opin; 2017 Nov; 33(11):2009-2017. PubMed ID: 28532174
[TBL] [Abstract][Full Text] [Related]
19. Impact of a previous cancer history on the overall survival of patients with primary gastric cancer: A SEER population-based study.
Chen Y; Sun R; Liu W
Eur J Surg Oncol; 2022 Oct; 48(10):2159-2165. PubMed ID: 35760621
[TBL] [Abstract][Full Text] [Related]
20. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
[Next] [New Search]
